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Case Report
Minimal Change Nephrotic Syndrome with IgM Deposits in
Kimura’s Disease: A Case Report and Literature Review
Sze-Kit Yuen, Sai-Ping Yong, Wilson Man-Shan Tsui,1 Fung-Yee Siu, Hing-Sum Tsui, King-On Cheung
Kimura’s disease is a rare condition of unknown etiology. It has been reported to be associated with nephrotic
syndrome, but the causal relationship and etiological mechanism have not been confirmed. We report a case of
steroid-responsive minimal-change nephrotic syndrome with immunoglobulin M deposits 2 years after the
diagnosis of Kimura’s disease. A review of the English-language literature from 1998 to May 2004 revealed a
total of eight cases of nephrotic syndrome in patients with Kimura’s disease. Six had nephrotic syndrome
before the diagnosis of Kimura’s disease was made, four of whom needed dialysis. The relationship between
Kimura’s disease and nephropathy is discussed. [Hong Kong J Nephrol 2004;6(2):97–102]
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Kimura’s disease is a rare condition predominantly
affecting Orientals, although sporadic cases in other
ethnicities have been reported [1–6]. It was first de-
scribed by Kimm and Szeto in 1937 [7], but became
better known after the work of Kimura et al [8]. It was
once confused with angiolymphoid hyperplasia with
eosinophilia [9], but these are now recognized as distinct
entities that should be differentiated [2,10].
A typical patient is an otherwise healthy male of,
mostly, Asian origin, aged between 20 and 40 years,
presenting with single or multiple subcutaneous lumps
and/or lymphadenopathy in the head and neck region
[10–12]. The lumps are usually painless and may last
for months to years [11]. Ultrasound and computed
tomography (CT) findings are not diagnostic [13,14].
According to Buggage et al, peripheral eosinophi-
lia is present in 98% of cases; fewer cases show raised
immunoglobulin (Ig) E titers [15]. Other immunoglo-
bulins may be variably affected, but are not known to be
grossly elevated [16].
Although cytologic features have been described
previously, excisional biopsy of the lump is essential to
exclude malignancy [17]. The diagnostic gold standard
for Kimura’s disease essentially involves histology
of excised specimens: follicular lymphoid hyperpla-
sia, heavy eosinophilic infiltration with or without eo-
sinophilic abscess formation, proliferation of post-
capillary venules, vascularization of germinal centers,
frequent occurrence of Warthin-Finkeldey polykaryo-
cytes, and sclerosis [2,10,18]. Immunohistochemistry
may show IgE reticular networks in germinal centers
and IgE-coated non-degranulated mast cells [18,19].
While the pathogenesis has not been established,
Kimura’s disease is commonly regarded to be as-
sociated with proteinuria [20]. We report a case of
minimal-change nephrotic syndrome with IgM depos-
its developing 2 years after the diagnosis of Kimura’s
disease.
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A 24-year-old male first presented with bilateral cer-
vical lymphadenopathy in August 2000. Fine needle
aspiration cytology showed reactive changes and
subsequent excisional biopsy confirmed the diagnosis
of Kimura’s disease (Figure 1). There was no further
treatment and a few small subcutaneous lymph nodes
persisted over the neck.
The patient presented to our unit in June 2003 with
generalized edema of a few days’ duration. There
was no family history of renal or autoimmune disease.
He took no regular medication. Physical examination
revealed a well-built man with gross lower-limb ede-
ma. There was no skin rash or arthritis, and blood
pressure was normal. Multiple bilateral lymph nodes
were palpable over the cervical area, the largest one
being up to 1 cm in diameter. There were no other pal-
pable regional lymph nodes.
The patient was eosinophilic (1.9 × 109/L; reference
range, 0.04–0.44 × 109/L). Electrolytes were normal.
Albumin and globulin concentrations were 20 g/L
and 28 g/L, respectively. The erythrocyte sedimenta-
tion rate was 36 mm/hour and total cholesterol was
11.24 mmol/L. Urinalysis revealed albuminuria (+++),
microscopic hematuria (1–4/μL), and the presence of
granular and hyaline casts. Creatinine clearance was
76.39 mL/min/1.73 m2 and urinary total protein was
6.79 g/day. Tests for hepatitis B surface antigen and
anti-hepatitis C virus antibody were negative. C3 and
C4 levels were only marginally elevated. The antinu-
clear factor titer was 1:80 and the test for anti-double-
stranded DNA was negative. The antistreptolysin O titer
was less than 200 U/mL. Ultrasound assessment showed
normal-sized kidneys with increased echogenicity.
The renal biopsy specimen was 8 mm long with
23 well-preserved glomeruli. Glomerular cellulari-
ty, basement membrane, tubules, and vessels were
all normal apart from hyaline droplet change in the
proximal tubules. There was no interstitial fibrosis or
tubular atrophy (Figure 2). Immunofluorescence of the
specimen revealed IgM(+) deposits in the glomerular
mesangium in a focal segmental and finely granular
pattern; there were no other immunodeposits. Elec-
tron microscopy revealed diffuse fusion of epithe-
lial processes and microvilli formation. There was al-
so a small to moderate amount of mesangial and para-
mesangial deposits. A few giant mitochondria were
noted in the tubules. The focal pattern of IgM deposi-
tion and the absence of diffuse mesangial expansion
or cell proliferation support the pathologic diagnosis
of minimal-change nephrotic syndrome rather than
IgM nephropathy.
The patient was subsequently started on diuretics
and prednisolone 1 mg/kg/day. IgE was still elevated
at 3 weeks (227 IU/mL; reference range, < 100 IU/mL).
Other immunoglobulins were not elevated. CT of the
thorax, abdomen, and pelvis showed no evidence of
lymphadenopathy in other regions.
He responded dramatically to prednisolone. Pro-
teinuria fell to 0.14 g/day after only 3 weeks of ste-
roid treatment. At 5 months, there had been no recur-
rence of proteinuria despite a tailing dose of pred-
nisolone 5 mg daily. Eosinophilia improved but per-
sisted. The neck lymph nodes fluctuated in size but
never disappeared.
Figure 1. Lymph node featuring vascularized germinal center (right
upper corner), eosinophilic infiltrate (left upper corner), abundant
postcapillary venules (left center), and a traversing fibrous band
(hematoxylin & eosin, original magnification × 200).
Figure 2. Renal biopsy showing a glomerulus with normal cel-
lularity, no mesangial expansion, and basement membrane of
normal thickness (hematoxylin & eosin, original magnification
× 600).
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DISCUSSION
Kimura’s disease is commonly regarded as associated
with proteinuria. In spite of limited available data, at
least three pathogenic mechanisms have been proposed
(Figure 3). It is thought that an as yet unknown stimulus
triggers an aberrant immune response [18,19], mani-
fested as an imbalance between T helper 1 and T help-
er 2 cell activity [21–23]. The first proposed mecha-
nism highlights the importance of skin lesions in the
pathogenesis of nephropathy in Kimura’s disease.
Katagiri et al noted a drop in the levels of interleukin
(IL)-4, IL-5, and IL-13 mRNA in peripheral blood
mononuclear cells of affected patients when the mass
was removed or treated with radiotherapy [22].
Unfortunately, this mechanism cannot explain why
some patients develop nephropathy prior to the
development of subcutaneous lumps, though one may
argue that the lumps are subclinical. In the second
proposed mechanism, cytokines play pivotal roles in
causing both the nephrotic syndrome and clinical
manifestations of the disease. Different permeability
factors appear to be implicated in causing abnormal
glomerular permeability in nephrotic syndrome [24].
Different cytokines may modify production of these fac-
tors [25]. In the third proposed mechanism, a common
etiologic factor causes both direct damage to the kid-
ney and an aberrant immune response. However, no
identifiable antigen in renal biopsies has so far been
reported. Alternatively, nephropathy and other clinical
features of Kimura’s disease may be part of a systemic
atopic phenomenon that may not be temporally related
[26].
According to previous reviews, 12–16% of patients
with Kimura’s disease have proteinuria, among whom,
62–79% reach the nephrotic range [20,27]. On the other
hand, in a reported series of 40 cases from Hong Kong,
only one patient developed nephrotic syndrome [10].
Membranous glomerulonephritis is the most
common renal lesion reported in patients with Kimu-
ra’s disease [28]. Other reported renal lesions include
minimal-change nephrotic syndrome [29], mesangio-
proliferative glomerulonephritis [30,31], focal segmen-
tal glomerulosclerosis [32], and IgA nephropathy [28].
Figure 3. Proposed pathogenic mecha-
nisms of Kimura’s disease. (A) The first
proposed mechanism highlights the im-
portance of skin lesions in the patho-
genesis of nephropathy in Kimura’s dis-
ease. (B) In the second proposed mech-
anism, cytokines play pivotal roles in
causing both the nephrotic syndrome
and clinical manifestations of the dis-
ease. (C) In the third proposed mecha-
nism, a common etiologic factor causes
both direct damage to the kidney and an
aberrant immune response. PBMC = pe-
ripheral blood mononuclear cell; PF =
permeability factor; IL = interleukin.
A
B
C
Unknown trigger Lymphocyte
activation
in skin lesions
of susceptible
individuals
PBMC
recruitment
Cytokines
(e.g. IL-5)
PF
Nephropathy
Unknown trigger
Non-specific
aberrant immune
response with
altered T cell
immunoregulation
Cytokines
(e.g. IL-5, IL-4)
PF
Nephropathy
Lymphocyte and mast cell
activation, eosinophil
infiltration of skin in
susceptible individuals
Unknown trigger
Non-specific
aberrant immune
response with
altered T cell
immunoregulation
Nephropathy
Cytokines
(e.g. IL-5, IL-4)
Lymphocyte and mast cell
activation, eosinophil
infiltration of skin in
susceptible individuals
S.K. Yuen, et al
100 Hong Kong J Nephrol • October 2004 • Vol 6 • No 2
Renal disease typically follows the appearance of
skin lesions, though this chronologic sequence is not
necessary [20].
Up to 1982, 21 cases of nephropathy in patients with
Kimura’s disease had been reported in the literature,
all involving male patients [20]. A subsequent review
covering the period from 1981 to 1998 found an addi-
tional 12 cases, 10 of which involved male patients [28].
Our search of the English literature from 1998 to May
2004 (including our case) revealed eight more cases of
Kimura’s disease with nephropathy (Table). Reported
patients were 9 to 35 years of age and male. It is intuitive
to speculate that male gender is a risk factor for renal
involvement in Kimura’s disease, but a conclusion can-
not yet be reached, given the small number of reported
cases. In contrast to a previous review [28], in most
of the recently reported cases (6 of 8), nephrotic syn-
drome preceded the diagnosis of Kimura’s disease,
and four patients needed dialysis. Although one may
speculate that the presence of nephropathy preceding
soft-tissue masses in Kimura’s disease is associated
Table. Reported cases of nephrotic syndrome in patients with Kimura’s disease in the English literature since 1998
Year Ethnicity
Age (yr)/ Onset of Proteinuria Serum Peak IgE Peak eosino- Renal Response Need
Sex proteinuria* (g/day) creatinine level (normal phil (% total pathology Treatment to for
(μmol/L) range) WCC) treatment dialysis
1998 [32] Brazilian 9/M† 1 year before 4.32 106 – 55% FSGS Prednisolone No Yes
(Caucasian) 17/M† Lump improved > 3 Normalized – Normal FSGS, Cyclosporine, No Yes
chronic azathioprine,
rejection prednisolone
1998 [28] Vietnamese 24/M 7–8 years before 5.4 80 – 16% IgA ne- Pulsed methyl- Yes No
phropathy prednisolone and
prednisolone
2000 [33] Japanese 11/M ~1 year after 18 27 1,000 U/mL 23% N/A Prednisolone/ Yes No
(< 500) cyclosporine
2000 [31] Vietnamese 14/M 5 years before 4 62 – 11% MPGN Prednisolone Poor Yes
(transiently also
chlorambucil)
2001 [34] Chinese 32/M 1 year 8 months > 300 mg/dL 2,705 17,300 IU/mL 57% N/A Prednisolone N/A Yes
(Taiwan) before (for the lump)
2002 [30] Thai 12/M 4 years before 7 71 210 IU/dL 37% MPGN Prednisolone/ Poor No
(30–140) cyclophosphamide
2003 [35] Chinese 35/M > 10 years – 1,017 1,350 mg/L 20% FSGS Steroid (for N/A Yes
(Taiwan) before (30–280) the lump)
2004 [this Chinese 24/M 3 years after 6.79 86 227 IU/mL 18% MCNS Prednisolone Yes No
paper] (Hong Kong) (< 100)
*Related to the time of first appearance of subcutaneous lesion(s); †the case report described recurrence of FSGS in the same child after
kidney transplantation. WCC = white cell count; FSGS = focal segmental glomerulosclerosis; N/A = data not available or not applicable;
MPGN = mesangioproliferative glomerulonephritis; MCNS = minimal-change nephrotic syndrome. (Note: to convert serum creatinine
in μmol/L to mg/dL, multiply by 0.0113.)
with poor prognosis due to some unidentified factor,
end-stage renal failure in these cases may be better
accounted for by the natural progression of the renal
pathology itself (Table).
Although Kimura’s disease is commonly regarded
as associated with nephrotic syndrome, readers are
reminded that this impression originates from a lit-
erature review by Yamada et al [20], who noted a high
prevalence of proteinuria among all cases of Kimu-
ra’s disease that had been reported in the literature
by 1982. This might, at least partly, be attributed to
under-reporting of uncomplicated Kimura’s disease
and/or over-reporting of coincidental nephropathy (i.e.
report bias). Isolated case reports of different renal le-
sions developing in patients with Kimura’s disease
have since been published [28]. Concomitant response
of the subcutaneous mass and nephropathy to treat-
ment might seem to offer further evidence of the asso-
ciation [33], when it is equally probable that steroid
may treat reactive lymphadenopathy and nephropathy
independently. Nevertheless, not only has a causal
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relationship never been established, but the exact
prevalence and incidence of nephropathy among
patients with Kimura’s disease are not known. To
determine the exact prevalence of nephropathy, one
needs to gather a group of patients with Kimura’s
disease and screen them all for proteinuria. In the
few case series that are available, proteinuria was
uncommon [10–12,18].
Coronary artery spasm [21], myocardial infarction
[36], asthma [37], ulcerative colitis [38], and lichen
amyloidosis [39] have also been associated with Ki-
mura’s disease. These associations should be viewed
with skepticism for similar reasons.
Steroids are effective in inducing remission of sub-
cutaneous masses and lymphadenopathy in Kimura’s
disease, although relapse may occur when treatment
is stopped [33]. Surgical excision is commonly per-
formed to exclude malignancy. Radiotherapy is effec-
tive [40], but may not be appropriate for a benign con-
dition. Non-steroidal anti-inflammatory drugs [41],
pentoxifylline [42], cyclosporine [22], interferon-alpha
[43], and all-trans-retinoic acid [44] have all been used
with variable success. It is uncertain if these treatments
are also effective against concomitant nephrotic syn-
drome.
Optimal treatment regimens and long-term prog-
nosis for renal lesions in patients with Kimura’s dis-
ease are largely unknown due to the rarity of these
lesions and the lack of long-term follow-up data in the
literature. Usual standard treatment protocols should
be adopted and patients offered dialysis, if necessary.
There is no evidence that nephropathy in Kimura’s dis-
ease carries an exceptionally poor outcome. Steroid
treatment, particularly with prednisolone, is commonly
used as first-line treatment (Table).
In this article, we have described a typical case of
steroid-responsive minimal-change nephrotic syndrome
in a patient with Kimura’s disease. Although a wide
range of renal lesions have been reported in patients
with Kimura’s disease, risk of progression to end-stage
renal failure is probably predicted by the renal patho-
logy itself. Even if Kimura’s disease and nephropathy
are associated, the link is more likely to be non-specific
and to depend on individual susceptibility. The patho-
genesis of Kimura’s disease is obscure and treatment
is anecdotal. More research into the natural history of
the disease and its pathogenesis and associations is
warranted.
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